Dear Editor,

Previous studies have identified risk factors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) severe outcomes preferentially among hospitalized patients; therefore, they may have understated the denominator of such estimations \[[@CR1], [@CR2]\]. We aimed to determine pre-hospital risk factors and estimate individual probabilities of SARS-CoV2 severe outcomes among a nationwide cohort of cases of SARS-CoV2 infection, including those with and without hospitalization.

This was a retrospective analysis from a nationwide prospective registry, including confirmed (nasal/pharynx swab real-time polymerase chain reaction) cases of SARS-CoV2 infection notified to the Directorate-General of Health from March 02 until April 21, 2020, in Portugal. Primary endpoint was a composite of ICU admission or all-cause mortality until April 21. Multivariable analysis was performed with logistic regression. Internal validation was performed with bootstrapping. Models' performance was studied with calibration plots, *c*-statistic, and Brier score \[[@CR3], [@CR4]\]. Significance level was *α* = 0.05. Informed consent was waived due to the use of anonymized data and the current state of public health emergency.

Overall, 18,647 cases were included in our analyses, following exclusion of 1623 (8.0%) cases without hospital admission status and 23 (0.1%) cases without outcome status.

Among all cases, median (IQR) age was 50 (36--66) years (Table [1](#Tab1){ref-type="table"}). Male sex accounted for 7701 (41.3%) of all cases. While 15,651 (83.9%) cases did not have any comorbidity, the remainder of cases had the following number of comorbidities: one in 2213 (11.9%) cases, 2 in 600 (3.2%) cases, and ≥ 3 in 183 (1.0%) cases. Table 1Baseline characteristics stratified by intensive care unit admission or all-cause mortality statusCharacteristic\
***n*** (%) or median (IQR)Overall (***n*** = 18,647)ICU or deceased (***n*** = 687)No ICU and survived (***n*** = 17,960)***P***\*Age (years)50 (36--66)80 (69--87)49 (35--64)\< 0.001Sex (male)7701 (41.3%)376 (54.7%)7325 (40.8%)\< 0.001Number of comorbidities\< 0.001 None15,651 (83.9%)298 (43.4%)15,353 (85.5%) 12213 (11.9%)233 (33.9%)1980 (11.0%) 2600 (3.2%)103 (15.0%)497 (2.8%)  ≥ 3183 (1.0%)53 (7.7%)130 (0.7%)Types of comorbidities Diabetes mellitus1056 (5.7%)128 (18.6%)928 (5.2%)\< 0.001 Respiratory841 (4.5%)94 (13.7%)747 (4.2%)\< 0.001 Neurological/muscular730 (3.9%)136 (19.8%)594 (3.3%)\< 0.001 Malignancy568 (3.0%)63 (9.2%)505 (2.8%)\< 0.001 Cardiovascular/kidney410 (2.2%)131 (19.1%)279 (1.6%)\< 0.001 Hematological201 (1.1%)35 (5.1%)166 (0.9%)\< 0.001 Liver102 (0.5%)11 (1.6%)91 (0.5%)\< 0.001 HIV infection99 (0.5%)13 (1.9%)86 (0.5%)\< 0.001Hospital admission2952 (15.8%)561 (81.7%)2391 (13.3%)\< 0.001Time from symptoms onset to hospital admission (days) (*n* = 1910)4 (2--7)4 (2--8)4 (2--7)0.37Follow-up (days) (*n* = 14,470)27 (19--33)27 (20--34)27 (19--33)0.13*IQR* interquartile range, *HIV* human immunodeficiency virus, *ICU* intensive care unit\*Chi-square (categorical variables) or Mann-Whitney (continuous variables) tests (*α* = 0.05)

Median (IQR) follow-up was 27 (19--33) days. Overall, 2952 (15.8%) or 258 (1.4%) cases required hospital or ICU admission, respectively. All-cause mortality occurred in 456 (2.4%) cases. Among these cases, 330 (72.4%) died following hospital admission and 126 (27.6%) died without any reported hospital admission.

There were 687 (3.7%) cases admitted to the ICU or deceased (Table [1](#Tab1){ref-type="table"}). Cases with ICU admission or non-survivors had higher median age (80 vs. 49 years; *P* \< 0.001) and were more frequently men (54.7% vs. 40.8%; *P* \< 0.001) than those that were not admitted to the ICU and survived.

Cases with ICU admission or non-survivors had more frequently any comorbidity than those that were not admitted to the ICU and survived (56.6% vs. 14.5%; *P* \< 0.001). All types of comorbidities were more frequently reported in cases with ICU admission or non-survivors than those that were not admitted to the ICU and survived.

In multivariable analysis with logistic regression, higher age (aOR 1.065), male sex (aOR 1.896), or higher number of comorbidities (aOR 2.953 if one vs. aOR 3.568 if 2 vs. aOR 6.002 if ≥ 3; *P* \< 0.001 for all comparisons) were associated with higher risk of ICU admission or all-cause mortality (Table [2](#Tab2){ref-type="table"}). Table 2Independent risk factors for intensive care unit admission or all-cause mortality**Risk factors** CharacteristicUnadjusted OR (95%CI)Adjusted OR (95%CI)*P*  Age (years)1.071 (1.066--1.076)1.065 (1.059--1.071)\< 0.001  Sex (male)1.755 (1.506--2.046)1.896 (1.608--2.236)\< 0.001  Number of comorbidities\< 0.001   None   16.063 (5.076--7.242)2.953 (2.450--3.560)\< 0.001   210.677 (8.389--13.589)3.568 (2.768--4.599)\< 0.001   ≥ 321.004 (14.960--29.491)6.002 (4.206--8.566)\< 0.001**Examples of predicted probabilities** Age (years)20406080 SexMaleFemaleMaleFemaleMaleFemaleMaleFemale Number of comorbidities  00.0020.0010.0070.0040.0250.0140.0830.046  10.0060.0030.0210.0110.0710.0390.2110.124  20.0070.0040.0260.0140.0840.0460.2440.146  ≥ 30.0120.0070.0420.0230.1340.0750.3510.222*OR* risk ratio, *95%CI* 95% confidence interval, *ICU* intensive care unitModel: *n* total = 18,647, *n* events of ICU admission or all-cause mortality = 687; *c*-statistic of 0.876 (95%CI 0.866--0.887); Brier score of 0.0322Probability of intensive care unit admission or all-cause mortality = *e*^*y*^/(*e*^*y*^ + 1)*y* = − 8.053 + 0.0627\*Age (years) + 0.6374\*Sex (male as one or female as zero) + *A* or *B* or *C* (*A* = 1.0786 if one comorbidity; *B* = 1.2668 if 2 comorbidities; *C* = 1.7847 if ≥ 3 comorbidities)

The model's calibration plot showed a very good predictive performance up to estimated probabilities of 0.20, after which threshold it overestimated such probabilities as they became less frequent. After bootstrapping (slope shrinkage estimate of 0.9959), the predictive equation was the following: *e*^*y*^/(1 + *e*^*y*^) where *y* = − 8.053 + 0.0627\*Age (years) + 0.6374\*Sex (male as one or female as zero) + *A* or *B* or *C* (*A* = 1.0786 if one comorbidity; *B* = 1.2668 if 2 comorbidities; *C* = 1.7847 if ≥ 3 comorbidities). This predictive model had a bootstrapped *c*-statistic of 0.876 (95% confidence interval 0.864--0.886) and a Brier score of 0.0323.

Among cases with SARS-CoV2 infection at an early phase of the epidemic in Portugal, pre-hospital characteristics like age, sex, and the number of comorbidities were useful to predict ICU admission or all-cause mortality \[[@CR5]\]. These findings may inform health policies designed to protect specific subgroups of the population and project allocation of health resources, especially while measures of containment are being eased in many countries.
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